Biotech News
Cingulate Announces U.S. Patent Issuance for CTx-2103, Further Validating PTR™ Technology Platform
New Patent Strengthens Cingulate’s Intellectual Property Portfolio While Company Maintains Focus on Advancing Lead ADHD Candidate CTx-1301 New Patent Strengthens Cingulate’s Intellectual Property Portfolio While Company Maintains Focus on Advancing Lead ADHD Candidate CTx-1301
